Body Composition Analyzers Market – Global Industry Size, Share, Trends, Opportunity, & Forecast Segmented By Product (Bio-impedance Analyzer, Skinfold Callipers, Hydrostatic Weighing Equipment, Air Displacement Plethysmography, Dual Energy X-ray Absorptiometry, Other), By End-User (Hospitals, Fitness Clubs and Wellness Centers, Academic and Research Centers, Other), By Region & Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 739.32 Million
CAGR (2026-2031)	8.34%
Fastest Growing Segment	Bio-Impedance Analyzer
Largest Market	North America
Market Size (2031)	USD 1195.54 Million

Market Overview

The Global Body Composition Analyzers Market will grow from USD 739.32 Million in 2025 to USD 1195.54 Million by 2031 at a 8.34% CAGR. Body composition analyzers are medical assessment devices designed to differentiate and quantify physiological components such as fat mass, lean muscle tissue, and visceral water content, typically utilizing bioelectrical impedance analysis or dual-energy X-ray absorptiometry. The market is fundamentally driven by the rising global prevalence of obesity and metabolic disorders, which necessitates precise monitoring tools for effective clinical intervention and long-term health management. Furthermore, the expanding geriatric population and the increasing integration of professional health monitoring protocols in non-clinical wellness centers contribute to the sustained demand for these diagnostic systems.

One significant challenge impeding broader market expansion is the high capital investment required for professional-grade devices, which restricts adoption in resource-limited healthcare settings and smaller medical practices. According to the World Obesity Federation, in 2025, the organization projected that the total number of adults living with obesity worldwide will reach 1.13 billion by 2030. This data indicates a substantially growing addressable market for body composition analysis, underscoring the critical need for accurate diagnostic solutions to assist in managing weight-related public health issues.

Key Market Drivers

The escalating global prevalence of obesity and metabolic disorders acts as a primary catalyst for the adoption of body composition analyzers in medical and clinical settings. Healthcare providers are increasingly moving beyond simple weight measurement to detailed composition analysis for diagnosing and managing conditions like type 2 diabetes and cardiovascular disease. This clinical shift is underscored by the urgent need for intervention; according to the World Obesity Federation, March 2025, in the 'World Obesity Atlas 2025', 1.6 million premature deaths from non-communicable diseases are caused by overweight and obesity annually. Consequently, hospitals and specialized clinics are investing in high-precision analyzers to monitor visceral fat and muscle mass, enabling more targeted therapeutic strategies for high-risk patient populations.

Simultaneously, the rapid expansion of the fitness, health club, and wellness center industry is fueling substantial market growth as facilities differentiate their services through professional-grade diagnostics. Gyms and rehabilitation centers now utilize these devices to provide members with tangible metrics on muscle gain and fat loss, directly enhancing member retention and service value. According to Planet Fitness, Inc., November 2025, in the 'Third Quarter 2025 Results', total revenue increased 13.0% to $330.3 million, reflecting the robust commercial demand for fitness services that necessitates such equipment. Furthermore, the broader consumer shift toward performance monitoring is evident; according to Garmin Ltd., in 2025, revenue from the fitness segment increased 30% in the third quarter, signaling a heightened market appetite for personal body monitoring technologies.

Download Free Sample Report

Key Market Challenges

The high capital investment required for professional-grade body composition analyzers significantly restricts market expansion, particularly within independent medical practices and community clinics. These diagnostic systems involve high upfront costs that often outweigh the immediate financial return for smaller facilities operating on tight margins. Consequently, resource-constrained healthcare providers frequently prioritize essential operational expenses over acquiring advanced assessment tools, effectively narrowing the potential customer base to large, well-funded institutions. This economic barrier hampers the widespread adoption necessary for robust market growth.

According to the American Hospital Association, in 2025, 94% of health care administrators expected to delay equipment upgrades to manage financial strain. This statistic demonstrates the direct correlation between budgetary pressures and the deferral of capital equipment purchases. When medical facilities face fiscal uncertainty, the procurement of non-emergency diagnostic technologies like body composition analyzers is often the first expenditure to be postponed. This hesitation to invest in new capital equipment creates a stagnant sales environment, directly impeding the broader integration of these devices into the global healthcare infrastructure.

Key Market Trends

The Integration of Artificial Intelligence for Predictive Health Analytics is transforming the market by enabling devices to transition from simple measurement tools to advanced prognostic engines. Manufacturers are leveraging vast datasets to train algorithms that can identify subtle physiological patterns, predicting health risks such as sarcopenia or visceral fat accumulation before clinical symptoms manifest. This capability allows for personalized intervention strategies, significantly elevating the utility of these systems in preventive medicine. According to InBody Co., Ltd., February 2024, in the '2024 InBody Report', the company utilized its cloud database of over 100 million global body composition data points to derive new medical insights, including the identification of regional health disparities like lean obesity rates.

The Proliferation of Portable and Home-Use Diagnostic Devices is democratizing access to body composition monitoring, shifting the primary point of care from hospitals to residential settings. This trend is driven by the miniaturization of bioelectrical impedance analysis sensors, which are now increasingly embedded in consumer-grade smart scales and handheld monitors, offering users continuous visibility into their physiological status. This consumer segment has become a substantial revenue stream for major medical device manufacturers. According to Omron Corporation, September 2024, in the 'Integrated Report 2024', the Healthcare Business reported that sales of body composition monitors accounted for 4% of the division's 145.9 billion yen total revenue, highlighting the solid commercial demand for these personal health management tools.

Segmental Insights

The Bio-Impedance Analyzer segment is identified as the fastest-growing category within the Global Body Composition Analyzers Market due to its non-invasive nature and operational cost efficiency. Unlike complex dual-energy X-ray absorptiometry systems, bio-impedance technology is highly portable and avoids radiation exposure, making it ideal for frequent use in fitness centers and home healthcare settings. This growth is further propelled by increasing global awareness regarding obesity management, encouraging healthcare providers to adopt these accessible devices for routine patient monitoring. Consequently, the combination of safety, affordability, and convenience drives the rapid expansion of this segment.

Regional Insights

North America maintains a leading position in the Global Body Composition Analyzers Market, primarily driven by the region's rising prevalence of obesity and metabolic disorders. This significant public health challenge necessitates accurate monitoring tools, fueling demand across the United States and Canada. The region benefits from a well-established healthcare infrastructure and high adoption rates of preventive wellness solutions in hospitals and fitness centers. Furthermore, stringent regulatory oversight by the U.S. Food and Drug Administration (FDA) ensures device reliability, fostering widespread clinical acceptance. This market strength is supported by continuous technological advancements from key industry players headquartered in the region.

Recent Developments

• In September 2024, Xiaomi introduced the Mijia Body Composition Scale S400 Pro in China, marking a new development in the consumer segment of the Global Body Composition Analyzers Market. This smart scale featured an integrated 3.5-inch color display, allowing users to view 25 different health indicators, including body fat percentage, muscle mass, and visceral fat, without needing a smartphone app immediately. The device utilized dual-frequency bioelectrical impedance measurements to ensure high accuracy, reportedly correlating closely with gold-standard DEXA scans. This product launch highlighted the company's focus on making professional-grade body composition analysis accessible for home health management.
• In June 2024, Seca TRU established a significant distribution partnership with Physical Company to expand the reach of its medical-grade body composition analyzers within the United Kingdom's fitness sector. This agreement designated the partner as the distributor for the Seca TRU device, which utilizes bioimpedance technology to validate training results. The collaboration focused on empowering gyms and health clubs to move beyond traditional weight tracking by offering members detailed insights into muscle mass and fat percentage. This strategic move aimed to support operators in positioning their facilities as hubs for holistic health and wellness monitoring.
• In May 2024, Withings Health Solutions entered a strategic partnership with LifeMD, a virtual primary care provider, to integrate advanced body composition analysis into weight management programs. This collaboration involved deploying the Withings Body Pro 2, a cellular body composition scale, to patients prescribed GLP-1 medications. The initiative allowed clinicians to monitor comprehensive biometric data, such as body fat and muscle mass, in near real-time. By leveraging this connected technology, the partnership aimed to enhance clinical decision-making and improve long-term health outcomes for patients by tracking metrics beyond simple weight loss.
• In March 2024, InBody Co., Ltd. expanded its portfolio in the Global Body Composition Analyzers Market by launching two next-generation devices, the InBody 380 and InBody 580, in the United States. These analyzers were engineered to enhance fitness and health assessments for professionals, with the InBody 380 featuring a portable, foldable design ideal for mobile consultations. The InBody 580 offered advanced capabilities, including detailed segmental analysis and bioelectrical impedance vector analysis graphs. This launch aimed to provide practitioners with precise, medical-grade tools to track client progress and deliver personalized health insights across various care settings.

Key Market Players

• Bodystat Ltd
• Cosmed S.R.L
• Hologic Inc.
• Inbody Co. Ltd
• Maltron International Ltd
• Omron Healthcare Inc.
• Seca GmbH & Co. Kg
• Tanita Corporation
• Fitbit Inc.
• Koninklijke Philips NV
• EatSmart Inc.

By Product	By End-User	By Region
Bio-impedance Analyzer Skinfold Callipers Hydrostatic Weighing Equipment Air Displacement Plethysmography Dual Energy X-ray Absorptiometry Other	Hospitals Fitness Clubs and Wellness Centers Academic and Research Centers Other	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Body Composition Analyzers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Body Composition Analyzers Market, By Product:

• Bio-impedance Analyzer
• Skinfold Callipers
• Hydrostatic Weighing Equipment
• Air Displacement Plethysmography
• Dual Energy X-ray Absorptiometry
• Other

• Body Composition Analyzers Market, By End-User:

• Hospitals
• Fitness Clubs and Wellness Centers
• Academic and Research Centers
• Other

• Body Composition Analyzers Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE